Trazodone PCD Pharma Franchise Company
Cafoli Lifecare is a trusted Trazodone PCD pharma franchise company offering 4 WHO-GMP certified formulations available in Tablets. We provide monopoly-based distribution rights to pharma entrepreneurs and distributors across India, backed by DCGI-approved quality and a reliable supply chain.
What is Trazodone?
Trazodone is a serotonin antagonist and reuptake inhibitor (SARI) antidepressant that also has sedative properties, which can help with sleep in people who have depression. It is a prescription-only medicine and should be used only under the supervision of a psychiatrist or physician. Read the compound profile on PubChem.
Available Trazodone Formulations
Cafoli Lifecare offers 4 Trazodone formulations for franchise partners. Available forms: Tablets. Every batch is manufactured at WHO-GMP certified facilities and supplied with full regulatory documentation. Pricing is shared on request.
Therapeutic Applications
Trazodone is used to treat depression, including depression associated with anxiety or difficulty sleeping. It is prescribed mainly by psychiatrists and general physicians.
Why Trazodone is a High-Potential Molecule for Distributors
Trazodone combines antidepressant action with a sleep benefit, making it a versatile mental-health molecule with steady repeat demand across psychiatric and general practice.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers district-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved products, attractive promotional inputs and dedicated marketing support to a growing network of 1000+ franchise partners across India. Our focus on quality and on-time supply makes us a preferred Trazodone franchise partner.
References
- PubChem: Trazodone
- PubMed research on Trazodone
Our formulations of Trazodone find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: